Confirms the utility of the 10 mg daily oral dose of Xanamem being studied in late-stage clinical trials in Alzheimer\'s disease and major depressive disorder
Partnership taps real-world data to accelerate clinical trials,research,and drug development in Japan.
\'Ramadan 2025 at a Glance\' report provides marketers actionable consumer insights to craft winning strategies during Ramadan
- Company receives leadership status and A- rating for efficient water resources management - Recognition reflects Samsung Biologics\' commitment to water security and implementing sustainable pract
HONG KONG,Feb. 12,2025--VanceAI,a provider of AI-powered photo enhancement,processing,and editing solutions,has released its new generative AI upscaling tool,AI Magic Upscaler. This advanced resolutio
Leading mobile brokerage will launch event contracts,meeting rising demand for the asset class NEW YORK,Feb. 12,2025--Webull,a leading digital investment platform,today announced that it has partnere
